Accordingly, Van Boxel et al. demonstrated that GERD patients experienced a notable increase in heartburn and nausea during a lipid infusion, which can be attributed to an increase in chylomicron production and secretion, which may trigger the release of cholecystokinin, a stimulant of vagal afferences [38]. Here, CCK is linked to gastroesophageal reflux disease.